You are here: Industry Insights > hydroxychloroquine

News List

COVID-19 treatments update: hydroxychloroquine and tocilizumab europeanpharmaceuticalreview
March 04, 2021
Find out what the WHO has to say about the use of hydroxychloroquine in COVID-19 prevention and the results of a severe COVID-19 pneumonia trial with tocilizumab.
WHO panel advises against use of hydroxychloroquine to prevent Covid-19 pharmaceutical-technology
March 03, 2021
The World Health Organization’s (WHO) Guideline Development Group (GDG) expert panel has made a recommendation against the use of the anti-inflammatory drug hydroxychloroquine to prevent Covid-19.
EMA highlights link between hydroxychloroquine and psychiatric disorders europeanpharmaceuticalreview
December 01, 2020
The EMA recommends updating the product information for chloroquine and hydroxychloroquine after confirming a link between these medicines and psychiatric disorders.
Researchers say hydroxychloroquine could still prevent COVID-19 pharmatimes
August 11, 2020
Leading scientific researchers from the University of Oxford have said that the antiviral medication hydroxychloroquine is being ‘discarded prematurely’ and could still have benefit against COVID-19.
Researchers says hydroxychloroquine could still prevent COVID-19 pharmatimes
August 07, 2020
Leading scientific researchers from the University of Oxford have said that the antiviral medication hydroxychloroquine is being ‘discarded prematurely’ and could still have benefit against COVID-19.
FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems fda
July 08, 2020
A summary of the FDA review of safety issues with the use of hydroxychloroquine and chloroquine to treat hospitalized patients with COVID-19 is now available.
WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death expresspharma
July 07, 2020
The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day.
UK regulator says COVID-19 prevention trial of hydroxychloroquine can resume expresspharma
July 01, 2020
The decision came after the drug was found in another UK trial to have no benefit for patients already infected with COVID-19, the pandemic disease caused by the new coronavirus.
Export ban on hydroxychloroquine lifted expresspharma
June 19, 2020
Though there were export restrictions, India exported paracetamol and hydroxychloroquine to more than 120 countries over the last two months.
MHRA suspends patient recruitment to UK COVID-19 hydroxychloroquine trials europeanpharmaceuticalreview
June 18, 2020
After evidence suggesting hydroxychloroquine has no benefit against COVID-19, the MHRA has suspended further recruitment to clinical trials investigating the drug in the UK.

Previous page 1 2 3 4 5 6 Next page